OCA at 16:08, 29 November 2023

2023-11-29T16:08:57Z

← Older revision		Revision as of 16:08, 29 November 2023
Line 1:		Line 1:

	==Crystal structure of the extended-spectrum class C beta-lactamase AmpC BER with the ordered R2 loop==		==Crystal structure of the extended-spectrum class C beta-lactamase AmpC BER with the ordered R2 loop==
	<StructureSection load='7cin' size='340' side='right'caption='[[7cin]]' scene=''>		<StructureSection load='7cin' size='340' side='right'caption='[[7cin]], [[Resolution\|resolution]] 1.79Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7CIN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7CIN FirstGlance]. <br>		<table><tr><td colspan='2'>[[7cin]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_coli_K-12 Escherichia coli K-12]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7CIN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7CIN FirstGlance]. <br>
	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7cin FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7cin OCA], [https://pdbe.org/7cin PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7cin RCSB], [https://www.ebi.ac.uk/pdbsum/7cin PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7cin ProSAT]</span></td></tr>		</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.7900636Å</td></tr>
			<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
			<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7cin FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7cin OCA], [https://pdbe.org/7cin PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7cin RCSB], [https://www.ebi.ac.uk/pdbsum/7cin PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7cin ProSAT]</span></td></tr>
	</table>		</table>
			== Function ==
			[https://www.uniprot.org/uniprot/A7TUE6_ECOLX A7TUE6_ECOLX]
			<div style="background-color:#fffaf0;">
			== Publication Abstract from PubMed ==
			AmpC BER is an extended-spectrum (ES) class C beta-lactamase with a two-amino-acid insertion in the H10 helix region located at the boundary of the active site compared with its narrow spectrum progenitor. The crystal structure of the wild-type AmpC BER revealed that the insertion widens the active site by restructuring the flexible H10 helix region, which is the structural basis for its ES activity. Besides, two sulfates originated from the crystallization solution were observed in the active site. The presence of sulfate-binding subsites, together with the recognition of ring-structured chemical scaffolds by AmpC BER, led us to perform in silico molecular docking experiments with halisulfates, natural products isolated from marine sponge. Inspired by the snug fit of halisulfates within the active site, we demonstrated that halisulfate 3 and 5 significantly inhibit ES class C beta-lactamases. Especially, halisulfate 5 is comparable to avibactam in terms of inhibition efficiency; it inhibits the nitrocefin-hydrolyzing activity of AmpC BER with a Ki value of 5.87 muM in a competitive manner. Furthermore, halisulfate 5 displayed moderate and weak inhibition activities against class A and class B/D enzymes, respectively. The treatment of beta-lactamase inhibitors (BLIs) in combination with beta-lactam antibiotics is a working strategy to cope with infections by pathogens producing ES beta-lactamases. Considering the emergence and dissemination of enzymes insensitive to clinically-used BLIs, the broad inhibition spectrum and structural difference of halisulfates would be used to develop novel BLIs that can escape the bacterial resistance mechanism mediated by beta-lactamases.

			Crystal structure of AmpC BER and molecular docking lead to the discovery of broad inhibition activities of halisulfates against beta-lactamases.,Jeong BG, Na JH, Bae DW, Park SB, Lee HS, Cha SS Comput Struct Biotechnol J. 2020 Dec 17;19:145-152. doi:, 10.1016/j.csbj.2020.12.015. eCollection 2021. PMID:33425247<ref>PMID:33425247</ref>

			From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
			</div>
			<div class="pdbe-citations 7cin" style="background-color:#fffaf0;"></div>

			==See Also==
			*[[Beta-lactamase 3D structures\|Beta-lactamase 3D structures]]
			== References ==
			<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
			[[Category: Escherichia coli K-12]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
	[[Category: Cha SS]]		[[Category: Cha SS]]
	[[Category: Jeong BG]]		[[Category: Jeong BG]]

OCA at 10:08, 19 May 2021

2021-05-19T10:08:51Z

← Older revision		Revision as of 10:08, 19 May 2021
Line 1:		Line 1:
	~~'''Unreleased structure'''~~

	~~The entry~~ 7cin is ~~ON HOLD until Paper Publication~~		==Crystal structure of the extended-spectrum class C beta-lactamase AmpC BER with the ordered R2 loop==
			<StructureSection load='7cin' size='340' side='right'caption='[[7cin]]' scene=''>
	~~Authors~~:		== Structural highlights ==
			<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7CIN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7CIN FirstGlance]. <br>
	~~Description~~:		</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7cin FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7cin OCA], [https://pdbe.org/7cin PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7cin RCSB], [https://www.ebi.ac.uk/pdbsum/7cin PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7cin ProSAT]</span></td></tr>
	[[Category: ~~Unreleased Structures~~]]		</table>
			__TOC__
			</StructureSection>
			[[Category: Large Structures]]
			[[Category: Cha SS]]
			[[Category: Jeong BG]]

OCA at 04:08, 5 August 2020

2020-08-05T04:08:11Z

← Older revision		Revision as of 04:08, 5 August 2020
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

	The entry 7cin is ON HOLD		The entry 7cin is ON HOLD until Paper Publication

	Authors:		Authors:

OCA: Protected "7cin" [edit=sysop:move=sysop]

2020-07-22T08:32:16Z

Protected "7cin" [edit=sysop:move=sysop]

← Older revision	Revision as of 08:32, 22 July 2020
(No difference)

OCA: New page: '''Unreleased structure''' The entry 7cin is ON HOLD Authors: Description: Category: Unreleased Structures

2020-07-22T08:32:14Z

New page: '''Unreleased structure''' The entry 7cin is ON HOLD Authors: Description: Category: Unreleased Structures

New page

'''Unreleased structure'''

The entry 7cin is ON HOLD

Authors:

Description:
[[Category: Unreleased Structures]]

7cin - Revision history

OCA at 16:08, 29 November 2023

OCA at 10:08, 19 May 2021

OCA at 04:08, 5 August 2020

OCA: Protected "7cin" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 7cin is ON HOLD Authors: Description: Category: Unreleased Structures